Assessment of safety and effectiveness: the clinical use of tofogliflozin in patients with type 2 diabetes mellitus
Not Applicable
- Conditions
- Type 2 diabetes mellitus
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 10000
Inclusion Criteria
Not provided
Exclusion Criteria
1.Hypersensitivity to tofogliflozin 2.Patients who had severe ketosis or diabetic coma or precoma 3.Severe infection or trauma, perioperative 4.End stage renal disease with hemodialysis or peritoneal dialysis 5.Patients whose participation is deemed inappropriate at the discretion of the attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method